REQUEST A DEMO
Total
USD $0.00
Search more companies

Rodec Pharma Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rodec Pharma Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Rodec Pharmaceuticals Private Limited is an unlisted company, incorporated on 18/11/1997. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24233DL1997PTC090729 and registration number is 090729. The company is a trade company, it is engaged in wholesale trading.

Legal Address
F-46, Pankaj Central Market I.P Extension, Patparganj
East Delhi; Delhi; Postal Code: 110092

Contact Details: Purchase the Rodec Pharma Limited report to view the information.

Basic Information
Total Employees:
Purchase the Rodec Pharma Limited report to view the information.
Outstanding Shares:
Purchase the Rodec Pharma Limited report to view the information.
Registered Capital:
Purchase the Rodec Pharma Limited report to view the information.
Incorporation Date:
November 18, 1997
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
58.98%
Purchase this report to view the information.
27.12%
Company Performance
Financial values in the chart are available after Rodec Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
27.29%
Total operating revenue
25.35%
Operating profit (EBIT)
27.03%
EBITDA
26.65%
Net Profit (Loss) for the Period
23.19%
Total assets
62.04%
Total equity
34.67%
Operating Profit Margin (ROS)
-0.02%
Net Profit Margin
-0.26%
Return on Equity (ROE)
-2.4%
Debt to Equity Ratio
40.61%
Quick Ratio
-0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?